Number of pages: 69
Posted: 18 Jan 2019
Lucille Stuani,
Marie Sabatier,
Pierre Millard,
Tony Palama,
Nathalie Poupin,
Estelle Saland,
Claudie Bosc,
Laure Tonini,
Lara Gales,
Camille Montersino,
Florence Castelli,
Tony Kaoma,
Thomas Farge,
Nicolas Broin,
Madi Cissé,
Mohsen Hosseini,
Clément Larrue, Feng Wang,
Natalia Baran,
Nathalie Saint-Laurent,
Pierre-Luc Mouchel,
Marine Fraisse,
Mathilde Gotanègre,
Noémie Gadaud,
Nesrine Aroua,
Cédric Cassan,
Laurent Fernando,
Evgenia Turtoi,
Héléna Boutzen,
Laurie Gayte,
Kiyomi Morita,
Andrew M. Futreal,
Maud Heuillet,
Lindsay Peyriga,
Emeline Chu-Van,
Laurent Le Cam,
Martin Carroll,
Mary A. Selak,
Norbert Vey,
Claire Calmettes,
Arnaud Pigneux,
Audrey Bidet,
Rémy Castellano,
Christophe Junot,
Andrei Turtoi,
Guillaume Cazals,
Justine Bertrand-Michel,
Pierre Bories,
Joe Marszalek,
Courtney Dinardo,
Koichi Takahashi,
Marina Konopleva,
Laetitia K. Linares,
Yves Gibon,
Yves Collette,
Frédéric Lopez,
Floriant Bellvert,
Fabien Jourdan,
Christian Récher,
Jean-Charles Portais and
Jean-Emmanuel Sarry
University of Toulouse 3, Paul Sabatier University - Toulouse Cancer Research Center, University of Toulouse 3, Paul Sabatier University - Toulouse Cancer Research Center, University of Toulouse 1 - Laboratory of Engineering of Biological Systems and Processes (LISBP), University of Toulouse 1 - Laboratory of Engineering of Biological Systems and Processes (LISBP), National Infrastructure of Metabolomics and Fluxomics - MetaToul-MetaboHUB, University of Toulouse 3, Paul Sabatier University - Toulouse Cancer Research Center, University of Toulouse 3, Paul Sabatier University - Toulouse Cancer Research Center, University of Toulouse 3, Paul Sabatier University - Toulouse Cancer Research Center, University of Toulouse 1 - Laboratory of Engineering of Biological Systems and Processes (LISBP), Aix-Marseille University - Institut Paoli-Calmettes, MetaboHUB-Paris - Laboratoire d’Etude du Métabolisme des Médicaments, Proteome and Genome Reserch Unit, University of Toulouse 3, Paul Sabatier University - Toulouse Cancer Research Center, University of Toulouse 3, Paul Sabatier University - Toulouse Cancer Research Center, University of Montpellier - Institute for Cancer Research in Montpellier, University of Toulouse 3, Paul Sabatier University - Toulouse Cancer Research Center, University of Toulouse 3, Paul Sabatier University - Toulouse Cancer Research Center, University of Texas at Houston - Department of Genomic Medicine, University of Texas at Houston - Department of Genomic Medicine, University of Toulouse 3, Paul Sabatier University - Toulouse Cancer Research Center, University of Toulouse 3, Paul Sabatier University - Toulouse Cancer Research Center, University of Toulouse 3, Paul Sabatier University - Toulouse Cancer Research Center, University of Toulouse 3, Paul Sabatier University - Toulouse Cancer Research Center, University of Toulouse 3, Paul Sabatier University - Toulouse Cancer Research Center, University of Toulouse 3, Paul Sabatier University - Toulouse Cancer Research Center, University of Bordeaux - Fruit Biology and Pathology, University of Toulouse 1 - Toxalim INRA laboratory, University of Montpellier - Institute for Cancer Research in Montpellier, University of Toulouse 3, Paul Sabatier University - Toulouse Cancer Research Center, University of Montpellier - Institute for Cancer Research in Montpellier, University of Texas at Houston - Department of Genomic Medicine, Louisiana State University, Baton Rouge - School of Medicine, University of Toulouse 1 - Laboratory of Engineering of Biological Systems and Processes (LISBP), University of Toulouse 1 - Laboratory of Engineering of Biological Systems and Processes (LISBP), MetaboHUB-Paris - Laboratoire d’Etude du Métabolisme des Médicaments, University of Montpellier - Institute for Cancer Research in Montpellier, University of Pennsylvania - Division of Hematology/Oncology, University of Pennsylvania - Division of Hematology/Oncology, Aix-Marseille University, Centre Hospitalier Universitaire (CHU) de Bordeaux - Clinical Hematology Service, Centre Hospitalier Universitaire (CHU) de Bordeaux - Clinical Hematology Service, Centre Hospitalier Universitaire (CHU) de Bordeaux - Biological Hematology Service, Aix-Marseille University - Institut Paoli-Calmettes, MetaboHUB-Paris - Laboratoire d’Etude du Métabolisme des Médicaments, University of Montpellier - Institute for Cancer Research in Montpellier, University of Montpellier - Laboratory of Physical Measurements, National Infrastructure of Metabolomics and Fluxomics - MetaToul-MetaboHUB, Onco-Occitanie Regional Oncology Network, University of Texas at Houston - Department of Genomic Medicine, University of Texas at Houston - Department of Leukemia, University of Texas at Houston - Department of Leukemia, University of Texas at Houston - MD Anderson Cancer Center, University of Montpellier - Institute for Cancer Research in Montpellier, University of Bordeaux - Fruit Biology and Pathology, Aix-Marseille University - Institut Paoli-Calmettes, University of Toulouse 3, Paul Sabatier University - Toulouse Cancer Research Center, University of Toulouse 1 - Laboratory of Engineering of Biological Systems and Processes (LISBP), National Infrastructure of Metabolomics and Fluxomics - MetaToul-MetaboHUB, University of Toulouse 3, Paul Sabatier University - Toulouse Cancer Research Center, University of Toulouse 1 - Laboratory of Engineering of Biological Systems and Processes (LISBP) and University of Toulouse 3, Paul Sabatier University - Toulouse Cancer Research Center
